Clinical Trial Update: Irinotecan in Treating Patients With Recurrent Glioma [Phase 2]

View source ↗

Summary

A Phase 2 trial of irinotecan in patients with recurrent glioma has completed; this update summarizes the trial status and results.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Glioma

Drugs mentioned

• Irinotecan (Irinotecan)

Snippet

Sponsor: Alliance for Clinical Trials in Oncology | Conditions: Brain and Central Nervous System Tumors | Phase 2 | Status: COMPLETED